|
A common blue food dye
seems to have caused the deaths of 2 patients
after it was used to color the liquid food pumped into their
stomachs, according to a new report in the New England Journal of Medicine.
The patients had been given food with FD&C
blue dye No. 1, after which their skin and blood turned a bluish-green.
Several hours later the patients, a 12 month old with Down's Syndrome
and a 54 year old with kidney failure, were dead.
The blue dye, made of coal
tar, is routinely added to the liquid
food to help doctors see whether any of the food is escaping from the
stomach. In healthy people, the food and the dye are not thought to leave
the digestive tract.
The three cases involved patients who had digestive
track tissues being destroyed by sepsis, a serious infectious condition.
The condition apparently allowed the dye to enter the bloodstream, causing
a deadly drop in blood pressure (hypotension) and an increase in acid
levels in the body's fluids and tissues (acidosis).
According to the researchers:
"During sepsis, gastrointestinal
permeability increases because of enterocyte death and loss of barrier
function at intercellular gaps. Thus, substances that are otherwise
nonabsorbable may be absorbed during sepsis."
The researchers note that Blue dye #1 was approved
by the FDA in 1982 after experiments in healthy animals indicated that
he dye was nontoxic and not absorbed.
Concerning the potential health dangers of the dye,
the authors state:
"Blue dye no. 1, a triphenylmethane
dye, is a potent inhibitor of mitochondrial respiration in vitro and
reduces oxygen consumption by a factor of eight in mitochondrial preparations
in vitro. It appears to inhibit energy transformation by blocking the
adenine nucleotide translocator (as is the case with atractyloside)."
The researchers note that although both patients
were hospitalized with serious illnesses, their condition was improving
before they received the dye.
Although researchers say the dye is not dangerous
to the vast majority of people, they are recommending "judicious
use" in patients with possible increased gastrointestinal permeability.
New England Journal
of Medicine October 5, 2000; 343; 1047-1048.
|